Your browser doesn't support javascript.
loading
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Coignard, Juliette; Lush, Michael; Beesley, Jonathan; O'Mara, Tracy A; Dennis, Joe; Tyrer, Jonathan P; Barnes, Daniel R; McGuffog, Lesley; Leslie, Goska; Bolla, Manjeet K; Adank, Muriel A; Agata, Simona; Ahearn, Thomas; Aittomäki, Kristiina; Andrulis, Irene L; Anton-Culver, Hoda; Arndt, Volker; Arnold, Norbert; Aronson, Kristan J; Arun, Banu K; Augustinsson, Annelie; Azzollini, Jacopo; Barrowdale, Daniel; Baynes, Caroline; Becher, Heiko; Bermisheva, Marina; Bernstein, Leslie; Bialkowska, Katarzyna; Blomqvist, Carl; Bojesen, Stig E; Bonanni, Bernardo; Borg, Ake; Brauch, Hiltrud; Brenner, Hermann; Burwinkel, Barbara; Buys, Saundra S; Caldés, Trinidad; Caligo, Maria A; Campa, Daniele; Carter, Brian D; Castelao, Jose E; Chang-Claude, Jenny; Chanock, Stephen J; Chung, Wendy K; Claes, Kathleen B M; Clarke, Christine L; Collée, J Margriet; Conroy, Don M; Czene, Kamila; Daly, Mary B.
Affiliation
  • Coignard J; Genetic Epidemiology of Cancer team, Inserm, U900, Paris, France.
  • Lush M; Institut Curie Paris, Paris, France.
  • Beesley J; Mines ParisTech Fontainebleau, Paris, France.
  • O'Mara TA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Dennis J; PSL University Paris, Paris, France.
  • Tyrer JP; Paris Sud University, Orsay, France.
  • Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • McGuffog L; Department of Genetics and Computational Biology QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Leslie G; Department of Genetics and Computational Biology QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Adank MA; Centre for Cancer Genetic Epidemiology, Department of Oncology University of Cambridge, Cambridge, UK.
  • Agata S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ahearn T; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Aittomäki K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Anton-Culver H; Family Cancer Clinic, The Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Arndt V; Immunology and Molecular Oncology, Unit Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Arnold N; Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
  • Aronson KJ; Department of Clinical Genetics, Helsinki University Hospital University of Helsinki, Helsinki, Finland.
  • Arun BK; Fred A. Litwin Center for Cancer Genetics Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Augustinsson A; Department of Molecular Genetics University of Toronto, Toronto, ON, Canada.
  • Azzollini J; Department of Epidemiology, Genetic Epidemiology Research Institute University of California Irvine, Irvine, CA, USA.
  • Barrowdale D; Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Baynes C; Department of Gynaecology and Obstetrics University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Becher H; Institute of Clinical Molecular Biology University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Bermisheva M; Department of Public Health Sciences, and Cancer Research Institute Queen's University, Kingston, ON, Canada.
  • Bernstein L; Department of Breast Medical Oncology University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bialkowska K; Department of Cancer Epidemiology, Clinical Sciences Lund University, Lund, 22242, Sweden.
  • Blomqvist C; Unit of Medical Genetics, Department of Medical Oncology and Hematology Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Bojesen SE; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Bonanni B; Centre for Cancer Genetic Epidemiology, Department of Oncology University of Cambridge, Cambridge, UK.
  • Borg A; Institute for Medical Biometrics and Epidemiology University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Brauch H; Institute of Biochemistry and Genetics Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  • Brenner H; Department of Population Sciences Beckman Research Institute of City of Hope, Duarte, CA, USA.
  • Burwinkel B; Department of Genetics and Pathology Pomeranian Medical University Szczecin, Szczecin, Poland.
  • Buys SS; Department of Oncology, Helsinki University Hospital University of Helsinki, Helsinki, Finland.
  • Caldés T; Department of Oncology Örebro University Hospital, Örebro, Sweden.
  • Caligo MA; Copenhagen General Population Study, Herlev and Gentofte Hospital Copenhagen University Hospital, Herlev, Denmark.
  • Campa D; Department of Clinical Biochemistry, Herlev and Gentofte Hospital Copenhagen University Hospital, Herlev, Denmark.
  • Carter BD; Faculty of Health and Medical Sciences University of Copenhagen, Copenhagen, Denmark.
  • Castelao JE; Division of Cancer Prevention and Genetics IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Chang-Claude J; Department of Oncology Lund University and Skåne University Hospital, Lund, Sweden.
  • Chanock SJ; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Chung WK; iFIT-Cluster of Excellence University of Tübingen, Tübingen, Germany.
  • Claes KBM; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Clarke CL; Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Collée JM; Molecular Epidemiology Group, C080 German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Conroy DM; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg University of Heidelberg, Heidelberg, Germany.
  • Czene K; Department of Medicine Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Daly MB; Molecular Oncology Laboratory CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
Nat Commun ; 12(1): 1078, 2021 02 17.
Article in En | MEDLINE | ID: mdl-33597508
ABSTRACT
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10-8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / BRCA2 Protein / Genome-Wide Association Study Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / BRCA1 Protein / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / BRCA2 Protein / Genome-Wide Association Study Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Document type: Article Affiliation country:
...